Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients

by Farolfi, Alberto, Silimbani, Paolo, Gallegati, Davide, Petracci, Elisabetta, Schirone, Alessio, Altini, Mattia, Masini, Carla
Published in Oncotarget (2017)

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

by Rocca, Andrea, Schirone, Alessio, Maltoni, Roberta, Bravaccini, Sara, Cecconetto, Lorenzo, Farolfi, Alberto, Bronte, Giuseppe, Andreis, Daniele
Published in Ther Adv Med Oncol (2016)

High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy

by Lupini, Laura, Moretti, Anna, Bassi, Cristian, Schirone, Alessio, Pedriali, Massimo, Querzoli, Patrizia, Roncarati, Roberta, Frassoldati, Antonio, Negrini, Massimo
Published in Sci Rep (2018)

A Phase II Study of a Dose-Density Regimen With Fluorouracil, Epirubicin, and Cyclophosphamide on Days 1 and 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel i...

by Pietri, Elisabetta, Andreis, Daniele, Fabbri, Francesca, Menna, Cecilia, Schirone, Alessio, Kopf, Barbara, Rocca, Andrea, Amadori, Dino, De Giorgi, Ugo
Published in Oncologist (2015)

Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer

by Maltoni, Roberta, Casadio, Valentina, Ravaioli, Sara, Foca, Flavia, Tumedei, Maria Maddalena, Salvi, Samanta, Martignano, Filippo, Calistri, Daniele, Rocca, Andrea, Schirone, Alessio, Amadori, Dino, Bravaccini, Sara
Published in Oncotarget (2017)

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

by Rocca, Andrea, Cecconetto, Lorenzo, Passardi, Alessandro, Melegari, Elisabetta, Andreis, Daniele, Monti, Manuela, Maltoni, Roberta, Sarti, Samanta, Pietri, Elisabetta, Schirone, Alessio, Fabbri, Francesco, Donati, Caterina, Nanni, Oriana, Fedeli, Anna, Faedi, Marina, Amadori, Dino
Published in Cancer Chemother Pharmacol (2017)

Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes

by Giotta, Francesco, Acito, Luigi, Candeloro, Giampiero, Del Medico, Pietro, Gadaleta-Caldarola, Gennaro, Giordano, Guido, Gueli, Rossana, Lugini, Antonio, Magri, Valentina, Mandarà, Marta, Masci, Giovanna, Pisconti, Salvatore, Pistelli, Mirco, Rizzi, Anna, Salesi, Nello, Schirone, Alessio, Scognamiglio, Giovanni, Tedeschi, Maria, Zucchinelli, Patrizia
Published in Oncologist (2016)

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

by Pietri, Elisabetta, Massa, Ilaria, Bravaccini, Sara, Ravaioli, Sara, Tumedei, Maria Maddalena, Petracci, Elisabetta, Donati, Caterina, Schirone, Alessio, Piacentini, Federico, Gianni, Lorenzo, Nicolini, Mario, Campadelli, Enrico, Gennari, Alessandra, Saba, Alessandro, Campi, Beatrice, Valmorri, Linda, Andreis, Daniele, Fabbri, Francesco, Amadori, Dino, Rocca, Andrea
Published in Oncologist (2018)

Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting

by Generali, Daniele, Montemurro, Filippo, Bordonaro, Roberto, Mafodda, Antonino, Romito, Sante, Michelotti, Andrea, Piovano, Pierluigi, Ionta, Maria Teresa, Bighin, Claudia, Sartori, Donata, Frassoldati, Antonio, Cazzaniga, Marina Elena, Riccardi, Ferdinando, Testore, Franco, Vici, Patrizia, Barone, Carlo Antonio, Schirone, Alessio, Piacentini, Federico, Nolè, Franco, Molino, Annamaria, Latini, Luciano, Simoncini, Edda Lucia, Roila, Fausto, Cognetti, Francesco, Nuzzo, Francesco, Foglietta, Jennifer, Minisini, Alessandro Marco, Goffredo, Francesca, Portera, Giuseppe, Ascione, Gilda, Mariani, Gabriella
Published in Oncologist (2017)